{
  "id": 14935776,
  "title": "Next-gen RNAi drugmaker City prices $200M IPO",
  "url": "https://urgent.news/2026/10/16/next-gen-rnai-drugmaker-city-prices-200m-ipo",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-16T10:33:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/city-therapeutics-ipo-price-rnai-drugs/832945/"
  },
  "original_language": "en",
  "account": null,
  "summary": "The offering will support a trio of medicines in or nearing clinical testing, as well as earlier research into RNAi treatments that get into tissues outside the liver.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}